advanced search

INJECTION

DETECTING THE COST OF POOR QUALITY: CONTRACT MANUFACTURING BEST PRACTICES
INJECTION
Leigh Toole
West Pharmaceutical Services
DETECTING THE COST OF POOR QUALITY: CONTRACT MANUFACTURING BEST PRACTICES
In this article, Leigh Toole provides some useful advice on how to assess and evaluate key aspects of a potential contract manufacturer partner in order to avoid pitfalls and to ensure the most fruitful relationship for both parties.
EDITORIAL COMMENT
EDITORIAL
Guy Furness
EDITORIAL COMMENT
Guy Furness, ONdrugDelivery Magazine's Editor, takes a moment to reflect on the topic of Prefilled Syringes, what's happening in the sector today and it's special place in the publication.
OVERCOMING THE CHALLENGES: COMBINING INJECTABLE DRUG WITH SELF-INJECTION DEVICE
PREFILLED SYRINGES
Steven Kaufman
OVERCOMING THE CHALLENGES: COMBINING INJECTABLE DRUG WITH SELF-INJECTION DEVICE
Steven Kaufman talks about a broad range of challenges that biopharmaceutical companies and their partners will likely face on the road to taking their biologics, biosimilars, generic injectables and even biobetters to market in combination products.
FAST & LOW-RISK CUSTOMISATION OF INNOVATIVE INJECTION SYSTEMS
PREFILLED SYRINGES
Dr Andreas Schneider
Ypsomed
FAST & LOW-RISK CUSTOMISATION OF INNOVATIVE INJECTION SYSTEMS
Andreas Schneider highlights new emerging requirements of biopharma companies and describes how Ypsomed has established a range of innovative platform products, based on proven expertise and capabilities, and well-honed development and manufacturing processes, in order to meet its biopharma partners’ and customers’ needs fully and completely.
INTRODUCTION TO LARGE VOLUME INJECTORS: PHARMA PERSPECTIVE
EXPERT VIEW
Paul Jansen
INTRODUCTION TO LARGE VOLUME INJECTORS: PHARMA PERSPECTIVE
Paul Jansen introduces the new "Injectable Delivery: Wearable Bolus Injectors" edition of ONdrugDelivery Magazine with insight into this technology from the pharmaceutical perspective.
EDITORIAL COMMENT
EDITORIAL
Guy Furness
EDITORIAL COMMENT
Guy Furness summarises the inaugural "Injectable Delivery: Wearable Bolus Injectors" edition of ONdrugDelivery Magazine.
PEOPLE POWER: INSPIRING & DELIVERING A UNIQUE WEARABLE BOLUS INJECTOR
WEARABLES
Mike Hooven
Enable Injections
PEOPLE POWER: INSPIRING & DELIVERING A UNIQUE WEARABLE BOLUS INJECTOR
In this article we describe the highly customisable wearable bolus injection device developed by Enable Injections to provide the most comfortable, simple and discreet patient experience.
INTEGRATED SOLUTIONS FOR THE DELIVERY OF HIGH-VOLUME BIOLOGICS
WEARABLES
Graham Reynolds
West Pharmaceutical Services
INTEGRATED SOLUTIONS FOR THE DELIVERY OF HIGH-VOLUME BIOLOGICS
 Graham Reynolds introduces the company’s wearable bolus injector, SmartDose, in the context of a fully integrated self injection technology platform offering using a standard primary container.
PATCHPUMP: EXPANDING THE LIMITS OF PARENTERAL ADMINISTRATION
WEARABLES
Marylyn Rigby
PATCHPUMP: EXPANDING THE LIMITS OF PARENTERAL ADMINISTRATION
Marylyn Rigby introduces the company’s PatchPump device, its design, mechanism of action, steps of use and current status of clinical development.
SAFE & RELIABLE PRIMARY DRUG CONTAINER MANUFACTURING
INJECTION
Gerresheimer
SAFE & RELIABLE PRIMARY DRUG CONTAINER MANUFACTURING
Gerresheimer, leader in the manufacture of parenteral drug delivery systems and primary packaging, including standard and customised glass vials, ampoules and cartridges, provides a brief overview of the manufacturing process.
LARGE-VOLUME INJECTOR ENABLES ANYTIME ANYWHERE DELIVERY OF PARENTERAL DRUGS
WEARABLES
Dr Pieter Muntendam
LARGE-VOLUME INJECTOR ENABLES ANYTIME ANYWHERE DELIVERY OF PARENTERAL DRUGS
Pieter Muntendam and Gerhard Mayer (Sensile Medical USA) and Lars Krinelke (Sensile) describe how their large-volume injection device allows subcutaneous selfadministration.
CRITERIA FOR SELECTING A WEARABLE INJECTOR TECHNOLOGY AND PARTNER
WEARABLES
Alan Shortall
CRITERIA FOR SELECTING A WEARABLE INJECTOR TECHNOLOGY AND PARTNER
Alan Shortall provides a detailed account of the significant opportunities that wearable injection devices present pharmaceutical and biotech companies.
PATRICK ALEXANDRE, CROSSJECT
INTERVIEW
Patrick Alexandre
PATRICK ALEXANDRE, CROSSJECT
Shortly after Crossject’s successful IPO on the French NYSE Euronext Paris Exchange (Paris Bourse), Patrick Alexandre spoke about Crossject, its technology and strategy for the future as a publically traded company.
TECHNOLOGY SHOWCASE: CROSSJECT’S ZENEO<sup>®</sup>
SKIN
Dr Tim Muller
TECHNOLOGY SHOWCASE: CROSSJECT’S ZENEO®
ZENEO® is a unique, automatic needle-free jet injector for SC, IM and ID routes, developed by Crossject. With ZENEO®, injection is fast, easy and secured.
Top